Genmab drug becomes more accessible in the US
Tepezza, which Genmab developed under the ownership of Horizon Therapeutics, has now entered the portfolio of products offered through the largest group of independent specialty pharmacies in the US.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Premier Pharmacy Services has now incorporated the Genmab-developed drug Tepezza in its product assortment, according to a press release from the pharmacy chain.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
